Fig. 4: Methylation changes with treatment. | Nature Communications

Fig. 4: Methylation changes with treatment.

From: Durvalumab and guadecitabine in advanced clear cell renal cell carcinoma: results from the phase Ib/II study BTCRC-GU16-043

Fig. 4: Methylation changes with treatment.

A Methylation at LINE-1 repetitive element regions, a decrease in methylation was observed in 22/25 patients between C1D1 and C2D8 timepoints. B Gartner-Aldman plot of change in CXCL10 methylation between first and second endpoints (n = 12). One-sided paired t test. Source data are provided as a source data file.

Back to article page